Signal Transduction and Targeted Therapy
Academic journal
From Wikipedia, the free encyclopedia
Signal Transduction and Targeted Therapy is a multidisciplinary, peer-reviewed, open access scientific journal covering biomedical research with a particular focus on signal transduction and its application to the drug development process. It was established in 2016 and is published by Nature Research. The editors-in-chief are David J. Kerr (Oxford University), Kang Zhang (Macau University of Science and Technology), and Yu-Quan Wei (West China Medical Center). According to the Journal Citation Reports, the journal has a 2024 impact factor of 52.7.[1]
| Discipline | |
|---|---|
| Language | English |
| Edited by |
|
| Publication details | |
| History | 2016–present |
| Publisher | |
| Frequency | Continuous |
| Yes | |
| 52.7 (2024) | |
| Standard abbreviations | |
| ISO 4 | Signal Transduct. Target. Ther. |
| Indexing | |
| ISSN | 2095-9907 (print) 2059-3635 (web) |
| LCCN | 2016243461 |
| OCLC no. | 1026877558 |
| Links | |
Abstract & Indexing
- Science Citation Index Expanded
- BIOSIS
- Open Access Journals (DOAJ)[2]
- MEDLINE[3]
- PubMed Central (PMC)
- Scopus
Sponsoring
The Journal is sponsored by West China Medical Center. [4]
